Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Current Assets (2016 - 2025)

Vycor Medical has reported Current Assets over the past 16 years, most recently at $563422.0 for Q4 2025.

  • Quarterly Current Assets fell 9.07% to $563422.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $563422.0 through Dec 2025, down 9.07% year-over-year, with the annual reading at $563422.0 for FY2025, 9.07% down from the prior year.
  • Current Assets was $563422.0 for Q4 2025 at Vycor Medical, down from $662596.0 in the prior quarter.
  • Over five years, Current Assets peaked at $743430.0 in Q3 2024 and troughed at $446451.0 in Q1 2021.
  • The 5-year median for Current Assets is $571748.5 (2021), against an average of $575382.4.
  • The largest YoY upside for Current Assets was 26.81% in 2021 against a maximum downside of 17.61% in 2021.
  • A 5-year view of Current Assets shows it stood at $487411.0 in 2021, then increased by 6.23% to $517763.0 in 2022, then increased by 12.81% to $584090.0 in 2023, then grew by 6.08% to $619614.0 in 2024, then decreased by 9.07% to $563422.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Current Assets are $563422.0 (Q4 2025), $662596.0 (Q3 2025), and $554355.0 (Q2 2025).